64.85 USD
+0.4 (+0.62%)
64.9 USD
+0.05 (+0.08%)
We assign a fundamental rating of 7 out of 10 to DXCM. DXCM was compared to 188 industry peers in the Health Care Equipment & Supplies industry. DXCM gets an excellent profitability rating and is at the same time showing great financial health properties. DXCM is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make DXCM suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year DXCM was profitable.
DXCM had a positive operating cash flow in the past year.
DXCM had positive earnings in each of the past 5 years.
In the past 5 years DXCM always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of DXCM (9.61%) is better than 92.02% of its industry peers.
The Return On Equity of DXCM (26.44%) is better than 96.81% of its industry peers.
With an excellent Return On Invested Capital value of 15.72%, DXCM belongs to the best of the industry, outperforming 95.74% of the companies in the same industry.
DXCM had an Average Return On Invested Capital over the past 3 years of 11.25%. This is above the industry average of 8.78%.
The last Return On Invested Capital (15.72%) for DXCM is above the 3 year average (11.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROIC | 15.72% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
DXCM has a Profit Margin of 15.96%. This is amongst the best in the industry. DXCM outperforms 92.02% of its industry peers.
In the last couple of years the Profit Margin of DXCM has grown nicely.
Looking at the Operating Margin, with a value of 18.41%, DXCM belongs to the top of the industry, outperforming 90.43% of the companies in the same industry.
DXCM's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 60.20%, DXCM perfoms like the industry average, outperforming 59.04% of the companies in the same industry.
In the last couple of years the Gross Margin of DXCM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
DXCM has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for DXCM has been increased compared to 1 year ago.
Compared to 5 years ago, DXCM has more shares outstanding
DXCM has a better debt/assets ratio than last year.
2.2 Solvency
DXCM has an Altman-Z score of 4.85. This indicates that DXCM is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.85, DXCM is in the better half of the industry, outperforming 77.13% of the companies in the same industry.
The Debt to FCF ratio of DXCM is 2.36, which is a good value as it means it would take DXCM, 2.36 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.36, DXCM belongs to the top of the industry, outperforming 86.70% of the companies in the same industry.
DXCM has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
DXCM has a Debt to Equity ratio (0.47) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 4.85 |
ROIC/WACC1.97
WACC7.98%
2.3 Liquidity
DXCM has a Current Ratio of 1.56. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
DXCM has a Current ratio of 1.56. This is in the lower half of the industry: DXCM underperforms 72.34% of its industry peers.
DXCM has a Quick Ratio of 1.38. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
DXCM's Quick ratio of 1.38 is on the low side compared to the rest of the industry. DXCM is outperformed by 60.64% of its industry peers.
The current and quick ratio evaluation for DXCM is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
DXCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.41%, which is quite good.
The Earnings Per Share has been growing by 29.25% on average over the past years. This is a very strong growth
The Revenue has grown by 14.21% in the past year. This is quite good.
DXCM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.27% yearly.
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
3.2 Future
The Earnings Per Share is expected to grow by 22.19% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 13.47% on average over the next years. This is quite good.
EPS Next Y27.59%
EPS Next 2Y24.04%
EPS Next 3Y22.49%
EPS Next 5Y22.19%
Revenue Next Year15.4%
Revenue Next 2Y14.3%
Revenue Next 3Y13.94%
Revenue Next 5Y13.47%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
DXCM is valuated quite expensively with a Price/Earnings ratio of 34.87.
Based on the Price/Earnings ratio, DXCM is valued a bit cheaper than 71.28% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.37. DXCM is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 25.54, DXCM can be considered very expensive at the moment.
73.40% of the companies in the same industry are more expensive than DXCM, based on the Price/Forward Earnings ratio.
DXCM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.20.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.87 | ||
| Fwd PE | 25.54 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DXCM is valued a bit cheaper than 75.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DXCM is valued cheaper than 85.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.82 | ||
| EV/EBITDA | 21.37 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of DXCM may justify a higher PE ratio.
A more expensive valuation may be justified as DXCM's earnings are expected to grow with 22.49% in the coming years.
PEG (NY)1.26
PEG (5Y)1.19
EPS Next 2Y24.04%
EPS Next 3Y22.49%
5. Dividend
5.1 Amount
No dividends for DXCM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
64.85
+0.4 (+0.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.73%
Inst Owner Change20.08%
Ins Owners0.19%
Ins Owner Change0.48%
Market Cap25.29B
Revenue(TTM)4.52B
Net Income(TTM)720.70M
Analysts85
Price Target88.3 (36.16%)
Short Float %3.45%
Short Ratio2.06
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)-15.5%
PT rev (3m)-16.28%
EPS NQ rev (1m)-4.28%
EPS NQ rev (3m)-4.66%
EPS NY rev (1m)0.62%
EPS NY rev (3m)0.73%
Revenue NQ rev (1m)-1.09%
Revenue NQ rev (3m)-1.25%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.87 | ||
| Fwd PE | 25.54 | ||
| P/S | 5.6 | ||
| P/FCF | 23.82 | ||
| P/OCF | 17.47 | ||
| P/B | 9.28 | ||
| P/tB | 9.64 | ||
| EV/EBITDA | 21.37 |
EPS(TTM)1.86
EY2.87%
EPS(NY)2.54
Fwd EY3.91%
FCF(TTM)2.72
FCFY4.2%
OCF(TTM)3.71
OCFY5.73%
SpS11.58
BVpS6.99
TBVpS6.73
PEG (NY)1.26
PEG (5Y)1.19
Graham Number17.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROCE | 19.96% | ||
| ROIC | 15.72% | ||
| ROICexc | 77.75% | ||
| ROICexgc | 88.6% | ||
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% | ||
| FCFM | 23.51% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 158.02% | ||
| Cap/Sales | 8.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 134.63% | ||
| Profit Quality | 147.34% | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 4.85 |
F-Score5
WACC7.98%
ROIC/WACC1.97
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
EPS Next Y27.59%
EPS Next 2Y24.04%
EPS Next 3Y22.49%
EPS Next 5Y22.19%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
Revenue Next Year15.4%
Revenue Next 2Y14.3%
Revenue Next 3Y13.94%
Revenue Next 5Y13.47%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year77.25%
EBIT Next 3Y38.83%
EBIT Next 5Y31.12%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%
DEXCOM INC / DXCM FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 7 / 10 to DXCM.
What is the valuation status for DXCM stock?
ChartMill assigns a valuation rating of 6 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.
Can you provide the profitability details for DEXCOM INC?
DEXCOM INC (DXCM) has a profitability rating of 9 / 10.
What are the PE and PB ratios of DEXCOM INC (DXCM) stock?
The Price/Earnings (PE) ratio for DEXCOM INC (DXCM) is 34.87 and the Price/Book (PB) ratio is 9.28.